Source:http://linkedlifedata.com/resource/pubmed/id/12019166
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2002-5-20
|
pubmed:abstractText |
Systemic or local administration of cytokine has been used as a mode to enhance the antitumor immune response induced by many cancer vaccines. We have investigated whether the expression of cytokines on the tumor cell surface as a glycolipid (GPI)-anchored form will be effective in inducing antitumor immune response using a GPI-anchored interleukin (IL)-12 (GPI-IL-12) as a model. GPI-IL-12-induced the proliferation of concanavalin A-activated T cells and induced IFN-gamma secretion by activated and allogeneic T cells, indicating that the membrane-expressed IL-12 can stimulate T cells. GPI-IL-12 expressed on the tumor cell surface prevented tumor growth in mice in a highly tumorigenic murine mastocytoma model. These results suggest that the cell surface-expressed GPI-IL-12 can be effective in inducing antitumor immune response, and GPI-anchored cytokines expressed on the tumor cell surface may be a novel approach to deliver cytokines at the immunization site during vaccination against cancer. Furthermore, purified GPI-anchored cytokines can be used to quickly modify tumor membranes by the protein transfer method to express the desired cytokines for vaccine development.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD59,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosylphosphatidylinositols,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2869-74
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12019166-Animals,
pubmed-meshheading:12019166-Antigens, CD59,
pubmed-meshheading:12019166-Cell Membrane,
pubmed-meshheading:12019166-Female,
pubmed-meshheading:12019166-Glycosylphosphatidylinositols,
pubmed-meshheading:12019166-Humans,
pubmed-meshheading:12019166-Interferon-gamma,
pubmed-meshheading:12019166-Interleukin-12,
pubmed-meshheading:12019166-Lymphocyte Activation,
pubmed-meshheading:12019166-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:12019166-Mast-Cell Sarcoma,
pubmed-meshheading:12019166-Mice,
pubmed-meshheading:12019166-Mice, Inbred DBA,
pubmed-meshheading:12019166-Rats,
pubmed-meshheading:12019166-Recombinant Fusion Proteins,
pubmed-meshheading:12019166-Spleen,
pubmed-meshheading:12019166-T-Lymphocytes,
pubmed-meshheading:12019166-Transfection
|
pubmed:year |
2002
|
pubmed:articleTitle |
Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|